| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60c16d764517cf3366a779080804ea4f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-502
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate |
1997-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0d4a1552bc5c642b9527aed6a9a1369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826795163629a396cea83088e669638b |
| publicationDate |
1997-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9725618-A1 |
| titleOfInvention |
Cytoplasmic modulators of integrin binding/signalling |
| abstract |
The present invention relates to methods to identify modulators of integrin binding and/or signalling activity. Specifically, the invention relates to a method to identify compounds which can alter the interaction between the cytoplasmic domain of a β1 integrin and a proteasome subunit protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9966065-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9966065-A3 |
| priorityDate |
1996-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |